The Psychiatric Genetics Consortium (PGC), a consortium of researchers led by scientists at University of California San Diego School of Medicine has made significant advancements in the understanding of the neurobiology of post-traumatic stress diso
In a subset of patients with high-risk prostate cancer, the combination of abiraterone acetate plus prednisone (AAP) and apalutamide may improve outcomes when added to salvage radiation therapy.
According to an article in ARRS' American Journal of Roentgenology, brain volume measurements in memory-impaired patients show significant differences and systematic biases between conventional and ultrafast 3D T1-weighted (T1W) MRI sequences.
Brain Volume and Memory Impairment: Conventional vs. Ultrafast 3D MRI Sequences itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SAN DIEGO, Jan. 14, 2021 /PRNewswire/ Cortechs.ai is pleased to announce the appointment of its new vice president of sales, Josh Cohen. The new appointment follows the acquisition of sister company Healthlytix and a company rebrand from CorTechs Labs to Cortechs.ai. Cortechs.ai is a leader in AI applications in radiology with FDA-cleared products for improved detection of neurodegenerative disease and cancer.
Josh brings over 12 years of proven commercial sales and leadership success. With expertise in business development and sales strategies in both large hospital health systems and outside the hospital space, Josh has a deep focus on integrated radiology solutions, informatics, and artificial intelligence to help healthcare providers deliver improved outcomes at a lower cost.